← All trials
NCT03255629
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 18, 2017
- Primary completion
- Aug 22, 2018
- Completion date
- Aug 22, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 23
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Joslin Diabetes CenterLead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- Harvard UniversityCollaborator
- National Institutes of Health (NIH)Collaborator
- Joslin Diabetes CenterOverall official - principal investigator
- Xeris PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.